Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
LETTER
Fu-Shan Xue, Xin-Tao Li, Lei Wan
No abstract text is available yet for this article.
September 28, 2023: American Journal of Obstetrics and Gynecology
#2
LETTER
Alex F Peahl, Claire Chang, Gwendolyn Daniels, Molly J Stout, Lisa Kane Low, Xilin Chen, Michelle H Moniz
No abstract text is available yet for this article.
September 28, 2023: American Journal of Obstetrics and Gynecology
#3
JOURNAL ARTICLE
Sarah S Lee, Andreea Dinicu, Likolani Arthurs, Danielle Shileds, Bhavana Pothuri, Michelle Ds Lightfoot
BACKGROUND: Participation in clinical trials may help mitigate disparate cancer outcomes. Ensuring equitable access to clinical trials is thus a major priority for national cancer organizations. OBJECTIVE: This study aimed to examine clinical trial eligibility criteria that may adversely impact the enrollment of underrepresented groups and assess the availability of demographic information in published gynecologic oncology studies. STUDY DESIGN: We searched clinicaltrials...
September 24, 2023: American Journal of Obstetrics and Gynecology
#4
JOURNAL ARTICLE
Sunitha Suresh, Alexa Freedman, Marci Adams, Emmet Hirsch, Linda M Ernst
BACKGROUND: Spontaneous preterm birth significantly increases the risk for a recurrent preterm birth (rPTB). Few identifiable clinical risk factors exist in counseling of rPTB. Furthermore, treatment with progesterone supplementation has not consistently prevented preterm birth in high-risk patients, but may be effective in a subset of such patients. Placental pathology from a prior pregnancy may be used to predict which patients will experience rPTB, or to identify a subset more likely to respond to treatment with antenatal progesterone...
September 24, 2023: American Journal of Obstetrics and Gynecology
#5
JOURNAL ARTICLE
Katherine T Chen, Laura Baecher-Lind, Christopher M Morosky, Rashmi Bhargava, Angela Fleming, Celeste S Royce, Jonathan A Schaffir, Shireen Madani Sims, Tammy Sonn, Alyssa Stephenson-Famy, Jill M Sutton, Helen Kang Morgan
BACKGROUND: Clerkship grades in obstetrics and gynecology play an increasingly important role in the competitive application process to residency programs. An analysis of clerkship grading practices has not been queried in the past two decades in our specialty. OBJECTIVE: To investigate obstetrics and gynecology clerkship directors' practices and perspectives in grading. STUDY DESIGN: A 12-item electronic survey was developed and distributed to clerkship directors with active memberships in the Association of Professors of Gynecology and Obstetrics...
September 23, 2023: American Journal of Obstetrics and Gynecology
#6
JOURNAL ARTICLE
Ramen H Chmait, Martha A Monson, Andrew H Chon, Ms Jinnen Masri, Lisa M Korst, Marc H Incerpi
BACKGROUND: Vasa previa is an obstetrical condition in which fetal vessels traverse the fetal membranes unprotected by underlying placenta and located near the cervix. Type I vasa previa arises directly from a velamentous cord root, while types II and III arise from an accessory lobe or a distal lobe of the same placenta, respectively. Fetoscopic laser ablation for types II and III vasa previa is a novel therapeutic option with benefits that include surgical resolution of the vasa previa, avoidance of prolonged hospitalization, and opportunity for a term vaginal delivery...
September 21, 2023: American Journal of Obstetrics and Gynecology
#7
JOURNAL ARTICLE
Grecio J Sandoval, William A Grobman, Scott R Evans, Madeline M Rice, Rebecca G Clifton, Suneet P Chauhan, Maged M Costantine, Kelly S Gibson, Monica Longo, Torri D Metz, Emily S Miller, Samuel Parry, Uma M Reddy, Dwight J Rouse, Hyagriv N Simhan, John M Thorp, Alan T N Tita, George R Saade
BACKGROUND: In randomized trials, one primary outcome is typically chosen to evaluate the consequences of an intervention while other important outcomes are relegated to secondary outcomes. This issue is amplified for many obstetric trials in which an intervention may have consequences for both the pregnant person and the child. In contrast, desirability of outcome ranking (DOOR), a paradigm shift for the design and analysis of clinical trials based on patient-centric evaluation, allows multiple outcomes - including from more than one individual - to be considered concurrently...
September 21, 2023: American Journal of Obstetrics and Gynecology
#8
JOURNAL ARTICLE
Tal Weissbach, Shir Lev, Adina Haimov, Abeer Massarwa, Idan Shamay, Roni Plaschkes, Lior Assa, Tal Elkan-Miller, Boaz Weisz, Gil Nardini, Noam Armon, Roni Sharon, Shali Mazaki Tovi, Eran Kassif
BACKGROUND: Prenatal diagnosis of cleft palate is challenging. Numerous 2D and 3D methods have been proposed to assess the integrity of the fetal palate, yet detection rate remains relatively low. We propose the "Hard Palate Sweep", a novel 2D method which enables a clear demonstration of the entire fetal palate throughout pregnancy, in a single sweep, avoiding acoustic shadows cast by surrounding bones. OBJECTIVE: This study aimed to assess the feasibility and performance of the "Hard Palate Sweep", performed throughout pregnancy...
September 21, 2023: American Journal of Obstetrics and Gynecology
#9
JOURNAL ARTICLE
Alan H Jobe, Robert L Goldenberg, Matthew W Kemp
Antenatal steroid therapy is increasingly central to the obstetric management of women at imminent risk of preterm birth. For women likely to deliver between 24 and 34 weeks' gestation, antenatal steroid therapy is standard of care, conveying sizable benefits and few risks in high-resource environments when appropriately targeted. Recent studies have focused on antenatal steroid use in periviable and late preterm populations, and in term cesarean deliveries. As a result, antenatal steroid therapy has now been applied from 22 weeks, to those delivered at 39+6 weeks estimated gestational age...
September 19, 2023: American Journal of Obstetrics and Gynecology
#10
JOURNAL ARTICLE
Valeria Lo Faro, Therese Johansson, Åsa Johansson
BACKGROUND: Over 150 million women worldwide use oral contraceptives. Women with inherited thrombophilia and carriers of certain thrombophilia gene variants, such as factor V Leiden and prothrombin mutation, are at increased risk of venous thromboembolism, especially in combination with oral contraceptive use. Venous thromboembolism is a complex disorder involving many genetic risk factors and recently polygenic risk scores have been proposed to capture a significant proportion of the genetic risk of venous thromboembolism...
September 19, 2023: American Journal of Obstetrics and Gynecology
#11
JOURNAL ARTICLE
Tia L Kauffman, Stephanie A Irving, Neon Brooks, Kimberly K Vesco, Matthew Slaughter, Ning Smith, Naomi K Tepper, Christine K Olson, Eric S Weintraub, Allison L Naleway
BACKGROUND: There is a growing literature base regarding menstrual changes following COVID-19 vaccination among premenopausal people. However, relatively little is known about uterine bleeding in postmenopausal people following COVID-19 vaccination. OBJECTIVES: To examine trends in incident postmenopausal bleeding diagnoses over time before and after COVID-19 vaccine introduction and describe cases of new-onset postmenopausal bleeding after COVID-19 vaccination...
September 17, 2023: American Journal of Obstetrics and Gynecology
#12
LETTER
Jason Gardosi, Oliver Hugh
No abstract text is available yet for this article.
September 16, 2023: American Journal of Obstetrics and Gynecology
#13
LETTER
Carbillon L
No abstract text is available yet for this article.
September 16, 2023: American Journal of Obstetrics and Gynecology
#14
LETTER
Floris Groenendaal
No abstract text is available yet for this article.
September 16, 2023: American Journal of Obstetrics and Gynecology
#15
JOURNAL ARTICLE
Peripartum extracorporeal cardiopulmonary resuscitation and rescue aspiration pulmonary embolectomy.
Marta V Antonini, Alessandro Circelli, Fabio F Tarantino, Luca Bissoni, Rita Pini, Patrizio Gm Antonazzo, Vanni Agnoletti
No abstract text is available yet for this article.
September 16, 2023: American Journal of Obstetrics and Gynecology
#16
JOURNAL ARTICLE
Touria Hajri, Mona Massoud, Margot Vergne, Pierre Descargues, Fabienne Allias, Benoit You, Jean-Pierre Lotz, Julie Haesebaert, Pierre-Adrien Bolze, François Golfier, Jerome Massardier
BACKGROUND: Multiple pregnancy with a complete hydatidiform mole and a normal fetus is prone to severe obstetrical complications and malignant transformation after birth. Prognostic information is limited for this rare form of gestational trophoblastic disease. OBJECTIVE: This study aimed to determine obstetrical outcomes and the risk of gestational trophoblastic neoplasia in women with multiple pregnancy with complete hydatidiform mole and coexisting normal fetus, and identify risk factors for poor obstetrical and oncological outcomes to improve patient information and management...
September 16, 2023: American Journal of Obstetrics and Gynecology
#17
JOURNAL ARTICLE
Lindsay R Freud, Stephanie Galloway, T Blaine Crowley, Julie Moldenhauer, Ann Swillen, Jeroen Breckpot, Antoni Borrell, Neeta L Vora, Bettina Cuneo, Hilary Hoffman, Lisa Gilbert, Beata Nowakowska, Maciej Geremek, Anna Kutkowska-Kaźmierczak, Joris R Vermeesch, Koen Devriendt, Tiffany Busa, Sabine Sigaudy, Trisha Vigneswaran, John M Simpson, Jeffrey Dungan, Nina Gotteiner, Karl-Philipp Gloning, Maria Cristina Digilio, Marta Unolt, Carolina Putotto, Bruno Marino, Gabriela Repetto, Magdalena Fadic, Sixto Garcia-Minaur, Ana Achón Buil, Mary Ann Thomas, Deborah Fruitman, Taylor Beecroft, Pui Wah Hui, Solveig Oskarsdottir, Rachael Bradshaw, Amanda Criebaum, Mary E Norton, Tiffany Lee, Miwa Geiger, Leslie Dunnington, Jacqueline Isaac, Louise Wilkins-Haug, Lindsey Hunter, Claudia Izzi, Marika Toscano, Tullio Ghi, Julie McGlynn, Francesca Romana Grati, Beverly S Emanuel, Kimberly Gaiser, J William Gaynor, Elizabeth Goldmuntz, Daniel E McGinn, Erica Schindewolf, Oanh Tran, Elaine H Zackai, Qi Yan, Anne Bassett, Ronald Wapner, Donna M McDonald-McGinn
BACKGROUND: 22q11.2 deletion syndrome (22qDS) is the most common microdeletion syndrome and is frequently associated with congenital heart disease (CHD). Prenatal diagnosis of 22qDS is increasingly offered. It is unknown whether there is a clinical benefit to prenatal detection as compared to postnatal diagnosis. OBJECTIVE: To determine differences in perinatal and infant outcomes between patients prenatally or postnatally diagnosed with 22qDS. STUDY DESIGN: Retrospective cohort study across multiple international centers (30 sites, 4 continents) from 2006 to 2019...
September 15, 2023: American Journal of Obstetrics and Gynecology
#18
REVIEW
Pier Carlo Zorzato, Stefano Uccella, Giulia Biancotto, Mariachiara Bosco, Anna Festi, Massimo Franchi, Simone Garzon
OBJECTIVE: To assess the effects on oncological outcomes of intrauterine manipulator use during laparoscopic hysterectomy for endometrial cancer. DATA SOURCES: A systematic literature search was performed by an expert librarian in multiple electronic databases from inception to January 31, 2023. STUDY ELIGIBILITY CRITERIA: We included all studies in the English language that compared oncologic outcomes (recurrence-free, cause-specific, or overall survival) between endometrial cancer patients who underwent total laparoscopic or robotic hysterectomy for endometrial cancer with versus without the use of an intrauterine manipulator...
September 11, 2023: American Journal of Obstetrics and Gynecology
#19
JOURNAL ARTICLE
Gabriella Schivardi, Jvan Casarin, Elizabeth B Habermann, Katherine A Bews, Carrie Langstraat, William Cliby, Giuseppe Cucinella, Luigi A DE Vitis, Pedro T Ramirez, Giovanni D Aletti, Andrea Mariani, Francesco Multinu
BACKGROUND: After the publication of the LACC trial, the standard surgical approach for early-stage cervical cancer is open radical hysterectomy. Only limited data were available regarding whether the change to open abdominal hysterectomy observed after the LACC trial led to an increase in post-operative complication rates as a consequence of the decrease in use of the minimally invasive approach. OBJECTIVE: The aim of the current study was to analyze whether there was a correlation with publication of the LACC trial and an increase in the 30-day complications associated with surgical treatment of invasive cervical cancer...
September 8, 2023: American Journal of Obstetrics and Gynecology
#20
JOURNAL ARTICLE
Emily L Gascoigne, Kyle R Roell, Lauren A Eaves, Rebecca C Fry, Tracy A Manuck
BACKGROUND: Epigenetic clocks use CpG DNA methylation (DNAm) to estimate biologic age; acceleration is associated with cancer, heart disease, and shorter lifespan. Few studies evaluate DNAm age and pregnancy outcomes. AgeAccelGrim is a novel epigenetic clock that combines seven DNAm components. OBJECTIVES: We sought to determine if maternal biologic aging (via AgeAccelGrim) is associated with early PTB. STUDY DESIGN: A prospective cohort of patients with singleton gestations and at high risk for spontaneous preterm birth (PTB) delivering at a tertiary University hospital were included in this study...
September 8, 2023: American Journal of Obstetrics and Gynecology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
